Theralase Signs Agreement with Urology Organization to Provide US Clinical Study Sites for its Phase II Non Muscle Invasive Bladder Cancer Clinical Study
Stock Information for Theralase Technologies Inc.
Loading
Please wait while we load your information from QuoteMedia.